Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method

Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2012-06, Vol.18 (5), p.562-566
Hauptverfasser: Bilgic, Basar, Bayram, Ali, Arslan, Ali Bilgin, Hanagasi, Hasmet, Dursun, Burcu, Gurvit, Hakan, Emre, Murat, Lohmann, Ebba
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 5
container_start_page 562
container_title Parkinsonism & related disorders
container_volume 18
creator Bilgic, Basar
Bayram, Ali
Arslan, Ali Bilgin
Hanagasi, Hasmet
Dursun, Burcu
Gurvit, Hakan
Emre, Murat
Lohmann, Ebba
description Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.
doi_str_mv 10.1016/j.parkreldis.2012.02.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1015244818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1353802012000752</els_id><sourcerecordid>1015244818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</originalsourceid><addsrcrecordid>eNqNUtuKFDEQbURx19VfkDz6MmOSvvsg6HiFBQX3PaTTlZnMdidtKr0yb_6GH-CP-SVWz6wr-CQUVBLOqVM5VVnGBF8LLqrn-_Wk43WEoXe4llzINacQ9b3sXDR1viqFrO7TOS_zVcMlP8seIe4553XJ84fZmZRFUcqiPc9-vnHWQgSfnE7ObxkeximFkS6GfSYR59k4J7oGj8zoGB1EZDaGkU30SkRk31zaMde7QC-7Ox4G_-v7D2TUI2iEF2wTfIqum5daLFim56MQ9AxhO1KlowrzMMfgRr1d2hkh7UL_OHtg9YDw5DZfZFfv3l5tPqwuP73_uHl1uTKFbNMKujYXFrTt8roSeVV1RWcKa2VptDVtW0vRN5XpWi7asukWq0peVX0uTWsoXWTPTmWnGL7OgEmNDg0Mg_YQZlTkPblWNKIhaHOCmhgQI1g1Reo5Hgi04Cq1V39npJYZKU4haqI-vVWZuxH6O-KfoRDg9QkA9NUb8luhIaMN9C6CSaoP7n9UXv5TxAzOO6OHazgA7sMcPVmphEIiqC_LriyrIuRxTWT-Gxrfw9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015244818</pqid></control><display><type>article</type><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</creator><creatorcontrib>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</creatorcontrib><description>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2012.02.017</identifier><identifier>PMID: 22445249</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Age of Onset ; Aged ; Analysis of Variance ; Automatic segmentation ; Basal Ganglia - pathology ; Brain Mapping ; Cognition Disorders - etiology ; Cognition Disorders - pathology ; Female ; Functional Laterality ; Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Middle Aged ; MRI ; Mutation - genetics ; Neurology ; Neuropsychological Tests ; Parkin gene ; Parkinson Disease - complications ; Parkinson Disease - genetics ; Parkinson Disease - pathology ; Parkinson’s disease ; Psychiatric Status Rating Scales ; Ubiquitin-Protein Ligases - genetics ; Young Adult</subject><ispartof>Parkinsonism &amp; related disorders, 2012-06, Vol.18 (5), p.562-566</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</citedby><cites>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.parkreldis.2012.02.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22445249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bilgic, Basar</creatorcontrib><creatorcontrib>Bayram, Ali</creatorcontrib><creatorcontrib>Arslan, Ali Bilgin</creatorcontrib><creatorcontrib>Hanagasi, Hasmet</creatorcontrib><creatorcontrib>Dursun, Burcu</creatorcontrib><creatorcontrib>Gurvit, Hakan</creatorcontrib><creatorcontrib>Emre, Murat</creatorcontrib><creatorcontrib>Lohmann, Ebba</creatorcontrib><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Automatic segmentation</subject><subject>Basal Ganglia - pathology</subject><subject>Brain Mapping</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - pathology</subject><subject>Female</subject><subject>Functional Laterality</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MRI</subject><subject>Mutation - genetics</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Parkin gene</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson’s disease</subject><subject>Psychiatric Status Rating Scales</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><subject>Young Adult</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUtuKFDEQbURx19VfkDz6MmOSvvsg6HiFBQX3PaTTlZnMdidtKr0yb_6GH-CP-SVWz6wr-CQUVBLOqVM5VVnGBF8LLqrn-_Wk43WEoXe4llzINacQ9b3sXDR1viqFrO7TOS_zVcMlP8seIe4553XJ84fZmZRFUcqiPc9-vnHWQgSfnE7ObxkeximFkS6GfSYR59k4J7oGj8zoGB1EZDaGkU30SkRk31zaMde7QC-7Ox4G_-v7D2TUI2iEF2wTfIqum5daLFim56MQ9AxhO1KlowrzMMfgRr1d2hkh7UL_OHtg9YDw5DZfZFfv3l5tPqwuP73_uHl1uTKFbNMKujYXFrTt8roSeVV1RWcKa2VptDVtW0vRN5XpWi7asukWq0peVX0uTWsoXWTPTmWnGL7OgEmNDg0Mg_YQZlTkPblWNKIhaHOCmhgQI1g1Reo5Hgi04Cq1V39npJYZKU4haqI-vVWZuxH6O-KfoRDg9QkA9NUb8luhIaMN9C6CSaoP7n9UXv5TxAzOO6OHazgA7sMcPVmphEIiqC_LriyrIuRxTWT-Gxrfw9M</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Bilgic, Basar</creator><creator>Bayram, Ali</creator><creator>Arslan, Ali Bilgin</creator><creator>Hanagasi, Hasmet</creator><creator>Dursun, Burcu</creator><creator>Gurvit, Hakan</creator><creator>Emre, Murat</creator><creator>Lohmann, Ebba</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><author>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Automatic segmentation</topic><topic>Basal Ganglia - pathology</topic><topic>Brain Mapping</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - pathology</topic><topic>Female</topic><topic>Functional Laterality</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MRI</topic><topic>Mutation - genetics</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Parkin gene</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson’s disease</topic><topic>Psychiatric Status Rating Scales</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bilgic, Basar</creatorcontrib><creatorcontrib>Bayram, Ali</creatorcontrib><creatorcontrib>Arslan, Ali Bilgin</creatorcontrib><creatorcontrib>Hanagasi, Hasmet</creatorcontrib><creatorcontrib>Dursun, Burcu</creatorcontrib><creatorcontrib>Gurvit, Hakan</creatorcontrib><creatorcontrib>Emre, Murat</creatorcontrib><creatorcontrib>Lohmann, Ebba</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bilgic, Basar</au><au>Bayram, Ali</au><au>Arslan, Ali Bilgin</au><au>Hanagasi, Hasmet</au><au>Dursun, Burcu</au><au>Gurvit, Hakan</au><au>Emre, Murat</au><au>Lohmann, Ebba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>18</volume><issue>5</issue><spage>562</spage><epage>566</epage><pages>562-566</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22445249</pmid><doi>10.1016/j.parkreldis.2012.02.017</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2012-06, Vol.18 (5), p.562-566
issn 1353-8020
1873-5126
language eng
recordid cdi_proquest_miscellaneous_1015244818
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Age of Onset
Aged
Analysis of Variance
Automatic segmentation
Basal Ganglia - pathology
Brain Mapping
Cognition Disorders - etiology
Cognition Disorders - pathology
Female
Functional Laterality
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Male
Middle Aged
MRI
Mutation - genetics
Neurology
Neuropsychological Tests
Parkin gene
Parkinson Disease - complications
Parkinson Disease - genetics
Parkinson Disease - pathology
Parkinson’s disease
Psychiatric Status Rating Scales
Ubiquitin-Protein Ligases - genetics
Young Adult
title Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A36%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiating%20symptomatic%20Parkin%20mutations%20carriers%20from%20patients%20with%20idiopathic%20Parkinson%E2%80%99s%20disease:%20Contribution%20of%20automated%20segmentation%20neuroimaging%20method&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Bilgic,%20Basar&rft.date=2012-06-01&rft.volume=18&rft.issue=5&rft.spage=562&rft.epage=566&rft.pages=562-566&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2012.02.017&rft_dat=%3Cproquest_cross%3E1015244818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1015244818&rft_id=info:pmid/22445249&rft_els_id=1_s2_0_S1353802012000752&rfr_iscdi=true